BMS-813160
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.
Product Specifications
CAS Number
1286279-29-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
484.64
Molecular Formula
C25H40N8O2
Notes
Research use only, not for human use.
Receptor
CCR2|CCR5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
